• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Gen Med . Hospital Readmissions of Discharged Patients with COVID-19

tetano

Editor, Senior Moderator
Int J Gen Med


. 2020 Dec 2;13:1359-1366.
doi: 10.2147/IJGM.S275775. eCollection 2020.
Hospital Readmissions of Discharged Patients with COVID-19


Lina Marcela Parra[SUP] 1 [/SUP], Mireia Cantero[SUP] 1 [/SUP], Ignacio Morr?s[SUP] 2 [/SUP], Alberto Vallejo[SUP] 1 [/SUP], Itziar Diego[SUP] 2 [/SUP], Elena Jim?nez-Tejero[SUP] 1 [/SUP], Elena M??ez[SUP] 3 [/SUP], ?ngel Asensio[SUP] 1 [/SUP], Ana Ferm?ndez-Cruz[SUP] 3 4 [/SUP], Antonio Ramos-Martinez[SUP] 3 4 [/SUP], Puerta de Hierro Hospital Admission Study Group



Affiliations

Abstract

Objective: To analyse the rate of occurrence and the clinical variables associated with readmission of patients who had previously been discharged after admission for COVID-19.
Setting: University hospital in Madrid (Spain).
Participants: Sixty-one patients (74% male) who presented COVID-19 were readmitted during the 3 weeks after discharge from hospital.
Interventions: Nested case-control study paired (1:1 ratio) by age, sex and period of admission.
Outcome measures: Rate of readmission rate of patients discharged after suffering COVID-19 and identification of the clinical variables associated with it.
Results: Out of 1368 patients who were discharged during the study period, 61 patients (4.4%) were readmitted. Immunocompromised patients (N=10.2%) were at increased risk for readmission (p=0.04). There was also a trend towards a higher probability of readmission in hypertensive patients (p=0.07). Cases had had a shorter hospital stay and a higher prevalence of fever during the 48 hours prior to discharge. There were no significant differences in oxygen levels measured at admission and discharge by pulse oximetry intra-subject or between the groups. Neutrophil-to-lymphocyte ratio at hospital admission tended to be higher in cases than in controls (p=0.06). Neither glucocorticoids nor anticoagulants prescribed at hospital discharge were associated with a lower readmission rate. Patients who were readmitted due to a thrombotic event (8 patients, 13.1%) presented a higher level of D-dimer at discharge of initial admission.
Conclusion: The rate of readmission after discharge from hospital for COVID-19 was low. Immunocompromised patients and those presenting with fever during the 48 hours prior to discharge were at greater risk of readmission to hospital.

Keywords: coronavirus; heparin; patient readmission; pneumonia; pulmonary embolism; viral.
 
Back
Top Bottom